LH Labcorp Holdings Inc. stock chart & analysis
Conviction 27HealthcareScan · Fri, Nov 6, 2026Labcorp Holdings Inc. (LH) closed at $366.57 (+0.90%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 70, RS Rating 93, -1.8% from its 52-week high, +46.1% year to date. Sector: Healthcare · Services-Medical Laboratories.
Financials as of Wed, Sep 30, 2026 · quarterly.
LH technical analysis
Trend
LH is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 12.6% above the 50-day ($325.65) and 26.5% above the 200-day ($289.84). ADX(14) at 35 points to a strong, established trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 70, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 93 puts its weighted 12-month performance ahead of about 93% of the US market, and its RS line is at a new high.
Volume and volatility
Volume on the latest session ran 0.6× its 20-day average. It trades about $259.9M a day on average. ATR(14) is $10.53, 2.9% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.23) shows accumulation.
Key levels
The chart pattern's support is $302.92 and its resistance $349.25. The 52-week range is $244.52 to $373.34; price is 1.8% below the high and 49.9% above the low. The VWAP anchored at the 52-week high is $365.23, below price.
Performance
LH returned +1.5% (1 week), +16.7% (1 month), +14.1% (3 months), +44.3% (6 months), +46.3% (1 year), +46.1% (year to date).
About Labcorp Holdings Inc.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Services-Medical Laboratories · Listed 1988 · 71,000 employees
Recent news
- Labcorp to Speak at the UBS Global Healthcare ConferencePR Newswire · Wed, Nov 4, 2026
Congress activity
Disclosed STOCK Act trades in LH · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 April McClain Delaney house · D · MD · traded 2026-08-07 | Sell | $1K–$15K | 2026-08-07 | 2026-09-09 | |
April McClain Delaney house · D · MD · traded 2026-08-06 | Sell | $1K–$15K | 2026-08-06 | 2026-09-09 | |
April McClain Delaney house · D · MD · traded 2026-08-05 | Sell | $1K–$15K | 2026-08-05 | 2026-09-09 | |
April McClain Delaney house · D · MD · traded 2026-08-25 | Sell | $100K–$250K | 2026-08-25 | 2026-09-09 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
April McClain Delaney house · MD · traded 2026-02-04 | Buy | $1K–$15K | 2026-02-04 | 2026-03-01 | |
April McClain Delaney house · D · MD · traded 2026-01-28 | Buy | $1K–$15K | 2026-01-28 | 2026-02-02 | |
April McClain Delaney house · MD · traded 2025-10-29 | Buy | $1K–$15K | 2025-10-29 | 2025-11-01 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Buy | $1K–$15K | 2025-05-15 | 2025-05-31 | |
Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-05-08 |
Insider activity
SEC Form 4 transactions in LH · open-market 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Vaughn Bryan T EVP and President, Diagnostics · Common Stock · 2026-11-03 | Sell | 306 | $108K | 2026-11-03 | 2026-11-05 |
Oyegunwa Akinbolade EVP, CIO & CTO · Common Stock · 2026-11-02 | Tax | 118 | $42K | 2026-11-02 | 2026-11-03 |
Vaughn Bryan T EVP and President, Diagnostics · Common Stock · 2026-11-02 | Tax | 194 | $69K | 2026-11-02 | 2026-11-03 |
Oyegunwa Akinbolade EVP, CIO & CTO · Restricted Stock Unit · 2026-11-01 | Exercise | 370 | — | 2026-11-01 | 2026-11-03 |
Oyegunwa Akinbolade EVP, CIO & CTO · Common Stock · 2026-11-01 | Exercise | 370 | — | 2026-11-01 | 2026-11-03 |
Vaughn Bryan T EVP and President, Diagnostics · Common Stock · 2026-11-01 | Exercise | 500 | — | 2026-11-01 | 2026-11-03 |
Vaughn Bryan T EVP and President, Diagnostics · Restricted Stock Unit · 2026-11-01 | Exercise | 500 | — | 2026-11-01 | 2026-11-03 |
Parham Richelle P Director · Common Stock · 2026-10-30 | Sell | 1.08K | $389K | 2026-10-30 | 2026-11-03 |
ANDERSON KERRII B Director · Common Stock · 2026-08-17 | Sell | 3K | $954K | 2026-08-17 | 2026-08-18 |
Schechter Adam H President & CEO · Common Stock · 2026-08-11 | Sell | 4.67K | $1.5M | 2026-08-11 | 2026-08-12 |
SEC filings
EDGAR filings in LH · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.